01.10.2009 | Clinical Trials Report
Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia
Erschienen in: Current Hematologic Malignancy Reports | Ausgabe 4/2009
Einloggen, um Zugang zu erhalten